跳至主要内容
临床试验/NCT01505699
NCT01505699已完成不适用

Micro RNA Expression Analysis in B-Lineage Adult Acute Lymphoblastic Leukemia From ALL Trial, E2993, Including Patients With Various Cytogenetic and Molecular Abnormalities

Eastern Cooperative Oncology Group0 个研究点目标入组 186 人开始时间: 2012年1月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
186
主要终点
Comprehensive view of microRNA expression by cytogenetic subgroup

研究概览

简要总结

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in samples from patients with acute lymphoblastic leukemia enrolled on ECOG-2993 clinical trial.

详细描述

OBJECTIVES:

  • To identify microRNAs that behave as oncogenes or as tumor suppressor genes in B-lineage acute lymphoblastic leukemia (ALL) in vitro and in vivo.
  • To examine if single microRNA or signatures of microRNA correspond to different clinical outcomes in cytogenetically distinct B-ALL groups.

OUTLINE: RNA from archived samples are analyzed for microRNA expression profile in vitro and in vivo.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
15 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Comprehensive view of microRNA expression by cytogenetic subgroup

时间窗: 1 year

MicroRNA expression in relation to clinical outcome

时间窗: 1 year

Differential microRNA expression between normal B-cells and progenitors compared to B-ALL

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验